Dementia: A silent killer which kills millions in its wake: An overview

K V Jinu; Sai Sailesh Kumar Goothy; Balaji Karunakaran

doi:10.53730/ijhs.v6nS2.6656

Authors

Jinu K V Assistant professor, Department of Physiology, D.M. Wayanad Institute of Medical Sciences, Wayanad, Kerala, India. 673577
Sai Sailesh Kumar Goothy Associate professor, Department of Physiology, R.D.Gardi Medical College, Ujjain, Madhya Pradesh, India. 456001
Balaji Karunakaran
drbalajikarunakaran@gmail.com
Professor, Department of Biochemistry, D.M. Wayanad Institute of Medical Sciences, Wayanad, Kerala, India. 673577

Keywords:

dementia, ageing, risk factors, cognition

Abstract

WHO defines dementia as a progressive chronic syndrome characterized by deterioration of cognitive function much beyond what is observed in the normal aging process. The impairment in various levels of cognitive functions such as short and long-term memory, abstract thinking, learning capability, orientation, comprehend various tasks, language, and judgment are commonly observed in patients with dementia. Further, the situation can get worsen by loss of emotional control, social behavior, motivation, etc., and this disability makes the dependency. A detailed literature review was performed through MEDLINE, Google, PubMed, Medline, Eric, Frontiers, and other online journals using the terms “Dementia”, “Risk factors of dementia”, “its types”, “prevalence”, and “available treatments of dementia”. The present article was based on these relevant terminologies. Progressive deterioration in cognition and motor functions is an undesired consequence of dementia, which has very limited diagnostic and therapeutic options. So, its quite mandatory to discover new diagnostic techniques as well as therapeutic strategies to conquer the challenge. Since pharmacological intervention only provides symptomatic relief, more and more non-pharmacological therapies should be invented in order to delay or prevent unhealthy aging.

Downloads

Download data is not yet available.

References

Schulz R, Sherwood PR. Physical and mental health effects of family caregiving. Am J Nurs. 2008 Sep; 108(9Suppl):23-7. doi: 10.1097/01.NAJ.0000336406.45248.4c

Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002 Nov;59(11):1737-46. doi: 10.1001/archneur.59.11.1737.

Urakami K, Adachi Y, Takahashi K. A community-based study of parental age at the birth of patients with dementia of the Alzheimer type. Arch Neurol. 1989 Jan;46(1):38-9. doi: 10.1001/archneur.1989.00520370040016.

Jouan-Flahault C, Seroussi MC, Colvez A (Absence of a relationship between senile dementia and parental age. A case report survey in Upper Normandy. Rev Epidemiol Sante Publique 1989; 37:73–5

Andersen K, Launer L.J, Dewey M.E, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology 1999; 53:1992–7

Ruitenberg A, Ott A, van Swieten J.C et al (2001). Incidence of dementia: does gender make a difference? Neurobiol Aging 2001; 22:575–80.

Richard F, Amouyel P (2001). Genetic susceptibility factors for Alzheimer’s disease. Eur J Pharmacol,412:1–12.

Corder E.H, Saunders A.M, Strittmatter W.J et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science1993; 261:921–3

Jesper Skov Neergaard, Neergaard JS, Dragsbæk K, Hansen HB et al. Late-Life Risk Factors for All-Cause Dementia and Differential Dementia Diagnoses in Women: A Prospective Cohort Study. Medicine (Baltimore) 2016; 95(11):1-7.

Liu C.K, Tai C.T, Lin R.T et al. Epidemiology of dementia in Taiwan. Appl Psychol Res 2000; 7:157–69.

Seloe D.J. Defining molecular targets to prevent Alzheimer disease. Arch Neurol 2005; 62:192–5.

Carter J, C. F Lippa..β-Amyloid, Neuronal Death and Alzheimers Disease. Current Molecular Medicine2001;1(6):733-7.

CostantinoIadecola .The Pathobiology of Vascular Dementia, Neuron 2013; 80[4(20)]:844-866.

WHO. Active aging: A policy framework health report Geneva. Geneva: World Health Organization; 2002

Ian McKeith. Demntia with Lewy bodies.Dialogues Clin Neurosci. 2004; 6(3): 333–341.

Das S, Paul N, Hazra A, Ghosal M, Ray BK, Banerjee T.K et al. Cognitive dysfunction in stroke survivors: Community‑based prospective study from Kolkata, India. J Stroke Cerebrovasc Dis. 2013; 22(8):1233-42.

Jotheeswaran AT, Williams JD, Prince MJ. Predictors of mortality among elderly people living in a South Indian urban community; a 10/66 Dementia research Group prospective population-based cohort study. BMC Public Health 2010; 10:366

Grutzendler J, Morris J.C. Cholinesterase inhibitors for Alzheimer’s disease. Drugs 2001; 61:41-52.

Hogan D.B, Bailey P, Carswell A et al. Management of mild to moderate Alzheimer’s disease and dementia. Alzheimers Dement 2007; 3:355-84

Rodda R, Carter J. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ 2012; 344: e2986.

Hogan D, Bailey P, Black S et al. Diagnosis and treatment of dementia: nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ 2008; 179:1019-26.

Jedrziewski M.K, Lee V.M.Y, Trojanowski T.Q. Physical activity and cognitive health. Alzheimer’s Dement2007; 3:98-108. 20.

Koger S.M, Brotons M. Music therapy for dementia symptoms. Cochrane Database Syst Rev 2000; (2):CD001121.

Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K (2009). Effect of aromatherapy on patients with Alzheimer's disease.Psychogeriatrics 2009;9(4):173-9.

Susan L. Filan and Robert H. Llewellyn-Jones. Animal-assisted therapy for dementia: a review of the literatureInternational Psychogeriatrics 2006;18(4):597–611

Juan Rodríguez-Mansilla, MaríaVictoria, González-López-Arza et al. Ear therapy and massage therapy in elderly people with dementia a pilot study. Journal of Traditional Chinese Medicine 2013; 33(4):461-46.